MINISTER OF STATE IN THE MINISTRY OF ROAD TRANSPORT AND HIGHWAYS; MINISTRY OF SHIPPING AND MINISTRY OF CHEMICALS AND FERTILIZERS (SHRI MANSUKH L. MANDAVIYA)
(a): As per the available data received from the various port offices of Central Drugs Standard Control Organization, hundreds of raw materials for manufacturing allopathic medicines have been imported from various countries. The percentage of import of raw materials from major countries for allopathic medicines is at Annexure ‘A’.
(b): As per the available data received from various port offices of Central Drugs Standard Control Organization, details of value of raw materials imported from various countries during last three years and current year is as follows:
Year Value (in Cr.)
2018 (till 28.01.2018) 574
2017 5097
2016 6495
2015 6477
The policies formulated by the government from time to time are made so that the country’s dependence on imports are minimised. In this direction, the Government had on 29.01.2016 notified the withdrawal of exemption in customs duties which were earlier given to certain categories of drugs and bulk drugs to provide a boost to the domestic manufacturers. Further, the government has removed bottlenecks in environment clearance etc. which the manufacturers were facing, in order to give a boost to domestic manufacturing of bulk drugs.
(c) & (d): The drugs imported from some of the companies in China were found ‘Not of Standard Quality’. The details of these companies and action taken by the Government is placed at Annexure-B. Further, The Central Drugs Standard Control Organization has directed Customs Collector to take necessary action as per Rule 41(1) of Drugs and Cosmetics Rules, 1945.
Annexure-A
The Details of the percentage of raw material imported country-wise in 2015
S. No. Country Name Percentage
(in terms of Value)
1 CHINA 66.14
2 ITALY 4.79
3 SINGAPORE 4.05
4 FINLAND 3.81
5 DENMARK 3.33
6 SWITZERLAND 2.43
7 GERMANY 2.08
8 SPAIN 1.87
9 USA 1.82
10 KOREA 1.49
11 Others 8.19
The Details of the percentage of raw material imported country-wise in 2016
S. No. Country Name Percentage
(in terms of Value)
1 CHINA 56.62
2 DENMARK 5.81
3 ITALY 5.08
4 FRANCE 3.95
5 USA 3.75
6 GERMANY 3.56
7 SPAIN 2.28
8 UNITED KINGDOM 1.84
9 KOREA 1.83
10 NETHERLAND 1.77
11 Others 13.53
The Details of the percentage of raw material imported country-wise in 2017
S. No. Country Name Percentage
(in terms of Value)
1 CHINA 68.62
2 GERMANY 4.61
3 USA 3.03
4 KOREA 2.48
5 NETHERLAND 2.23
6 DENMARK 2.20
7 MEXICO 2.05
8 SPAIN 2.01
9 UNITED KINGDOM 1.55
10 HUNGARY 1.50
11 Others 9.73
Annexure B
Year Details of drug Name of manufacturer and Country name Action Taken
2015
Bacitracin M/s. North China Pharmaceutical Huashong Co. Ltd., China CDSCO has communicated to Customs Collector to take necessary action as per Rule 41(1) of Drugs and Cosmetics Rules, 1945
Gelatin (Capsule Grade) Xiamen Gelkem, China
Oxytetracycline Hydrochloride M/S. Dafeng Tainsheng Pharmaceutical Co. Ltd., China.
2016 4-amino benzoyl-l-glutamic acid M/s Hanzhou Think Chemical Co. Ltd, China
Enoxparin Sodium Shenzehnen Technology Co. Ltd.,China Re sample sent To CDL, Kolkata
2017 11-Beta, 17 Alpha, 21-Trihydroxypregn-4-Ene-3,20-Dione M/S Zhejiang Pure Pharmaceuticals Co Ltd., China. CDSCO has communicated to Customs Collector to take necessary action as per Rule 41(1) of Drugs and Cosmetics Rules, 1945
2018
till date Metamizole Sodium Monohydrate EP/BP
Zhejiang Haisen Pharmaceutical Co Ltd, China
Under Process (Importer requested for Re-export of the Consignments)
Download PDF Files
